JAGSONPAL PHARMACEUTICALS
Back to Cashflow Statement
|
JAGSONPAL PHARMACEUTICALS Last 5 Year Cash Flow from Financing Activities History
[Standalone]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Cash Flow from Financing Activities | ₹-0.46 Cr | ₹-18 Cr | ₹-6.83 Cr | ₹-1.82 Cr | ₹-6.05 Cr |
What is the latest Cash Flow from Financing Activities ratio of JAGSONPAL PHARMACEUTICALS ?
Year | Cash Flow from Financing Activities |
---|---|
Mar2023 | ₹-0.46 Cr |
Mar2022 | ₹-18 Cr |
Mar2021 | ₹-6.83 Cr |
Mar2020 | ₹-1.82 Cr |
Mar2019 | ₹-6.05 Cr |
How is Cash Flow from Financing Activities of JAGSONPAL PHARMACEUTICALS Trending?
Years | Cash Flow from Financing Activities | % Change | |
---|---|---|---|
Mar2023 | ₹-0.46 Cr | Negative | |
Mar2022 | ₹-18 Cr | Negative | |
Mar2021 | ₹-6.83 Cr | Negative | |
Mar2020 | ₹-1.82 Cr | Negative | |
Mar2019 | ₹-6.05 Cr | - |
Compare Cash Flow from Financing Activities of peers of JAGSONPAL PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
JAGSONPAL PHARMACEUTICALS | ₹903.9 Cr | 2.7% | -2% | -3.6% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹354,706.0 Cr | -1.1% | -2.9% | 55.1% | Stock Analytics | |
CIPLA | ₹120,556.0 Cr | 0.3% | 6.1% | 56.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹118,095.0 Cr | 8.2% | 11.5% | 27.9% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹105,162.0 Cr | -3.7% | 8.5% | 107.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹100,086.0 Cr | 1.8% | -4.7% | 32.3% | Stock Analytics |
JAGSONPAL PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
JAGSONPAL PHARMACEUTICALS | 2.7% |
-2% |
-3.6% |
SENSEX | 0.4% |
1.1% |
20.6% |
You may also like the below Video Courses